Product logins

Find logins to all Clarivate products below.


Obesity Interventions | Market Insights | US | 2019

The US market for obesity interventions will grow moderately through 2027, driven by an increasing obese population and penetration of bariatric procedures due to positive clinical trials and improvements in insurance coverage.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the obesity intervention market in the US across a 10-year period.

Related Medtech Insights Reports

Report
Obesity Interventions – Market Insights – United States
The rise of GLP-1 receptor agonists is significantly transforming the landscape of obesity treatment, impacting the growth of bariatric procedures and affecting device sales. Innovations and future…
Report
Obesity Interventions | Market Insights | US | 2024
The US obesity intervention device market will show modest growth over the forecast period. Rising use of GLP-1 receptor agonists for obesity treatment will temporarily slow the growth of bariatric…
Report
Obesity Interventions | Market Insights | US | 2023
Procedure deferrals due to the COVID-19 pandemic severely impacted the US obesity intervention market in 2020, and the elective nature of many postponed procedures hindered the pace of recovery…
Report
Hernia Repair Devices | Market Insights | Global | 2020
The global hernia repair device market will be driven by rising hernia repair volumes as well as the increasing use of tension-free techniques. The growing use of laparoscopy in tension-free…
Report
Heart Valve Devices | Market Insights | Japan | 2020
The Japanese heart valve device market is large and expanding, with growth being driven primarily by the rapid adoption of THV devices and an aging population in this country. Additionally, as…